STING1 and neoplasm: Strategies like using Stimulator of Interferon Genes (STING) agonists like STING‐binding molecules and cyclic dinucleotide (CDN) derivatives along with ICIs therapy can effectively launch an anti‐tumor response by making tumors sensitive to ICIs.102